🧪
hypothesis

ATAC-seq accessibility separates causal from compensatory states in: Are DNA methylation changes in neurodegeneration causal drivers or protective conseq

Hypothesis

ATAC-seq accessibility separates causal from compensatory states in: Are DNA methylation changes in neurodegeneration causal drivers or protective conseq

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective adaptation.
🧬 ATAC-seq accessibility🩺 neurodegeneration🎯 Composite 34%💱 $0.55▼2.5%active
EvidencePending (0%)📖 6 cit🗣 2 debates✓ 6 support✗ 1 oppose
✓ All Quality Gates Passed
🏆 ChallengeValidate ATAC-seq chromatin accessibility as causal driver in neurodegeneration$500 →
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite34%

🧪 Overview

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective adaptation. The decisive experiment is to measure ATAC-seq accessibility before and after senescence stratification in stratified models.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["ATAC-seq Open Chromatin<br/>Tn5 Transposase Accessibility Map"]
    B["Cell-Type Regulatory Landscape<br/>Neuron Microglia Astrocyte Profiles"]
    C["Aging-Associated Accessibility<br/>Loss at Neuronal Enhancers"]
    D["TF Binding Site Exposure<br/>Altered Transcription Factor Access"]
    E["Gene Expression Changes<br/>Disease-Linked Activation or Silencing"]
    F["Causal Mechanism Discrimination<br/>Driver vs Compensatory Response"]
    A --> B
    B --> C
    C --> D
    D --> E
    B -.->|"resolves"| F
    A -.->|"tracks"| F
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix5 supports1 contradicts
Supports
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural Plast2016PMID:27313899medium
Supports
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell2020PMID:33031745medium
Supports
DNA repair deficiency and neurodegeneration.
Cell Cycle2007PMID:17700067medium
Supports
Human endogenous retrovirus-K contributes to motor neuron disease.
Sci Transl Med2015PMID:26424568medium
Supports
DNA damage and its links to neurodegeneration.
Neuron2014PMID:25033177medium
Contradicts
causal direction requires longitudinal perturbation
skeptic_round
📖 Linked Papers (10)Export BibTeX ↗
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell (2020) · PubMed:33031745 ↗
12 figures
Figure 1
Figure 1
No caption available
Figure S1
Figure S1
Elevated NF-κB and Type I IFN Signaling Because of TDP-43 In Vitro , Related to Figure 1 (A) Doxycycline (Dox inducible wild-type (WT) or ALS mutant (Q331K) T...
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.
Cell (2020) · PubMed:33031745 ↗
No figures
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural plasticity (2018) · PubMed:27313899 ↗
No figures
DNA Damage, Neurodegeneration, and Synaptic Plasticity.
Neural Plast (2016) · PubMed:27313899 ↗
No figures
Human endogenous retrovirus-K contributes to motor neuron disease.
Science translational medicine (2015) · PubMed:26424568 ↗
No figures
Human endogenous retrovirus-K contributes to motor neuron disease.
Science translational medicine (2015) · PubMed:26424568 ↗
No figures
DNA damage and its links to neurodegeneration.
Neuron (2014) · PubMed:25033177 ↗
No figures
DNA damage and its links to neurodegeneration.
Neuron (2014) · PubMed:25033177 ↗
No figures
DNA repair deficiency and neurodegeneration.
Cell cycle (Georgetown, Tex.) (2007) · PubMed:17700067 ↗
No figures
DNA repair deficiency and neurodegeneration.
Cell cycle (Georgetown, Tex.) (2007) · PubMed:17700067 ↗
No figures

🏥 Translation

🧬 3D Protein Structure — ATAC-SEQ

No curated PDB or AlphaFold mapping for ATAC-SEQ yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ATAC-seq accessibility →

No DepMap CRISPR Chronos data found for ATAC-seq accessibility.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.1808
Events (7d)
1
Price History
▼2.5%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF accessibility identifies compensatory states, THEN blocking chromatin opening at protective loci will worsen stress-induced neuronal survival by >=20% within 21 days.Perturbing protective-accessibility loci lowers neuronal survival by >=20% versus non-targeting controls under stress.— no observation —pending0.50
IF ATAC-seq accessibility separates causal from compensatory methylation states, THEN causal CpG drift loci will show concordant chromatin-accessibility change in the same cell type at >=60% of loci b>=60% of nominated causal CpG loci have matched ATAC-seq accessibility shifts in vulnerable cells at the pre-injury timepoint.— no observation —pending0.56
🔮 Falsifiable Predictions (2)
pendingconf 56%
IF ATAC-seq accessibility separates causal from compensatory methylation states, THEN causal CpG drift loci will show concordant chromatin-accessibility change in the same cell type at >=60% of loci before neurodegeneration markers rise.
Predicted outcome: >=60% of nominated causal CpG loci have matched ATAC-seq accessibility shifts in vulnerable cells at the pre-injury timepoint.
Falsification: <25% of loci show concordant accessibility or shifts occur only after injury markers rise.
pendingconf 50%
IF accessibility identifies compensatory states, THEN blocking chromatin opening at protective loci will worsen stress-induced neuronal survival by >=20% within 21 days.
Predicted outcome: Perturbing protective-accessibility loci lowers neuronal survival by >=20% versus non-targeting controls under stress.
Falsification: Survival changes by <5% despite validated accessibility blockade.
View on SciDEX ↗